Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain

Published byFay Lee Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain"— Presentation transcript:

1 Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain
Figure 3 | LGI1 and Caspr2 immunohistochemistry on rat brain. a | Leucine-rich glioma-inactivated 1 (LGI1) antibodies bind to the hippocampus, excluding the inner one-third of the dentate gyrus, which results in a typical pale strip (arrow). b | Contactin-associated protein-like 2 (Caspr2) antibodies produce diffuse staining of the hippocampus. c | Negative control, no staining. Scale bars: whole brain, 2,000 µm; hippocampus, 500 µm. van Sonderen, A. et al. (2017) The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis Nat. Rev. Neurol. doi: /nrneurol

Download ppt "Figure 3 LGI1 and Caspr2 immunohistochemistry on rat brain"

Similar presentations

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.

Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Nat. Rev. Neurol. doi:10/1038/nrneurol

Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 4 Progression-free survival, according to treatment group

Figure 4 Progression-free survival, according to treatment group
Figure 3 Life expectancy at birth in all countries included

Figure 3 Life expectancy at birth in all countries included
Figure 2 The US Centers for Disease Control and

Figure 2 The US Centers for Disease Control and
Figure 1 Histopathology of low-grade glioma

Figure 1 Histopathology of low-grade glioma
Figure 1 Carotid artery inflammation detected using 18F-FDG-PET

Figure 1 Carotid artery inflammation detected using 18F-FDG-PET
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Proposed mechanism of Guillain–Barré

Figure 2 Proposed mechanism of Guillain–Barré
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
FigS3 IHC analysis of Drosha and DGCR8 protein distribution in the hippocampus, frontal cortex and cerebellum of control cases. In the hippocampus both.

FigS3 IHC analysis of Drosha and DGCR8 protein distribution in the hippocampus, frontal cortex and cerebellum of control cases. In the hippocampus both.
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Expression of complement activation products in renal samples

Figure 2 Expression of complement activation products in renal samples
Figure 5 Number of AHSCT procedures for

Figure 5 Number of AHSCT procedures for
Figure 4 Neuromyelitis optica spectrum disorder brain lesions

Figure 4 Neuromyelitis optica spectrum disorder brain lesions
Nat. Rev. Neurol. doi: /nrneurol

Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Immunofluorescence pattern of patient septin-5-immunoglobulin G binding to mouse tissues Immunofluorescence pattern of patient septin-5-immunoglobulin.

Figure 1 Immunofluorescence pattern of patient septin-5-immunoglobulin G binding to mouse tissues Immunofluorescence pattern of patient septin-5-immunoglobulin.

Similar presentations

Ads by Google